EUVIMEDEUVIMED entdecken
Open Access

Non–High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events

Feitong Wu, David R Jacobs, Stephen R Daniels, Mika Kähönen, Jessica G Woo, Alan R Sinaiko, Jorma S A Viikari, Lydia A Bazzano, Julia Steinberger, Elaine M Urbina, Alison J Venn, Olli T Raitakari und 3 weitere

JAMA · 04.06.2024 · 331 (21) · 1834

DOI: 10.1001/jama.2024.4819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 04.06.2024. Verfasst von Feitong Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cholesterol, LDL, Dyslipidemias. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDDK NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Elevated non–high-density lipoprotein cholesterol (non–HDL-C; a recommended measure of lipid-related cardiovascular risk) is common in children and increases risk of adult cardiovascular disease (CVD). Whether resolution of elevated childhood non–HDL-C levels by adulthood is associated with reduced risk of clinical CVD events is unknown.

Objective

To examine the associations of non–HDL-C status between childhood and adulthood with incident CVD events. Design, Setting, and Participants Individual participant data from 6 prospective cohorts of children (mean age at baseline, 10.7 years) in the US and Finland. Recruitment took place between 1970 and 1996, with a final follow-up in 2019. Exposures Child (age 3-19 years) and adult (age 20-40 years) non–HDL-C age- and sex-specific z scores and categories according to clinical guideline–recommended cutoffs for dyslipidemia. Main Outcomes and Measures Incident fatal and nonfatal CVD events adjudicated by medical records.

Results

Over a mean length of follow-up of 8.9 years after age 40 years, 147 CVD events occurred among 5121 participants (60% women; 15% Black). Both childhood and adult non–HDL-C levels were associated with increased risk of CVD events (hazard ratio [HR], 1.42 [95% CI, 1.18-1.70] and HR, 1.50 [95% CI, 1.26-1.78] for a 1-unit increase in z score, respectively), but the association for childhood non–HDL-C was reduced when adjusted for adult levels (HR, 1.12 [95% CI, 0.89-1.41]). A complementary analysis showed that both childhood non–HDL-C levels and the change between childhood and adulthood were independently associated with the outcome, suggesting that from a preventive perspective, both childhood non–HDL-C levels and the change into adulthood are informative. Compared with those whose non-HDL-C levels remained within the guideline-recommended range in childhood and adulthood, participants who had incident non–HDL-C dyslipidemia from childhood to adulthood and those with persistent dyslipidemia had increased risks of CVD events (HR, 2.17 [95% CI, 1.00-4.69] and HR, 5.17 [95% CI, 2.80-9.56], respectively). Individuals who had dyslipidemic non–HDL-C in childhood but whose non-HDL-C levels were within the guideline-recommended range in adulthood did not have a significantly increased risk (HR, 1.13 [95% CI, 0.50-2.56]). Conclusions and Relevance Individuals with persistent non–HDL-C dyslipidemia from childhood to adulthood had an increased risk of CVD events, but those in whom dyslipidemic non–HDL-C levels resolve by adulthood have similar risk to individuals who were never dyslipidemic. These findings suggest that interventions to prevent and reduce elevated childhood non–HDL-C levels may help prevent premature CVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCholesterol, LDLDyslipidemiasAdolescentAdultChildChild, PreschoolFemaleHumansMaleYoung AdultCholesterolFinlandHeart Disease Risk FactorsIncidenceProspective StudiesUnited States

Substanzen

CholesterolCholesterol, LDL

Autor:innen und Institutionen

  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
  • Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis.
  • Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora.
  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland.

Förderung

  • NIA NIH HHS
  • NIDDK NIH HHS
  • NICHD NIH HHS
  • NHLBI NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NIEHS NIH HHS

Zitieren

APA

Wu, F., Jacobs, D. R., Daniels, S. R., Kähönen, M., Woo, J. G., Sinaiko, A. R., Viikari, J. S. A., Bazzano, L. A., Steinberger, J., Urbina, E. M., Venn, A. J., Raitakari, O. T., Dwyer, T., Juonala, M., & Magnussen, C. G. (2024). Non–High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events. JAMA, 331(21), 1834. https://doi.org/10.1001/jama.2024.4819

Vancouver

Wu F, Jacobs DR, Daniels SR, Kähönen M, Woo JG, Sinaiko AR, et al. Non–High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events. JAMA. 2024;331(21):1834. doi:10.1001/jama.2024.4819

BibTeX
@article{Wu2024,
  author = {Wu, Feitong and Jacobs, David R and Daniels, Stephen R and Kähönen, Mika and Woo, Jessica G and Sinaiko, Alan R and Viikari, Jorma S A and Bazzano, Lydia A and Steinberger, Julia and Urbina, Elaine M and Venn, Alison J and Raitakari, Olli T and Dwyer, Terence and Juonala, Markus and Magnussen, Costan G},
  title = {Non–High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events},
  journal = {JAMA},
  year = {2024},
  volume = {331},
  number = {21},
  pages = {1834},
  doi = {10.1001/jama.2024.4819}
}
Kostenlos starten →